PDF

Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials
Muhammad Ashar Ali

PDF

PARP Inhibitors for Treatment of BRCA1/2-Mutated Metastatic Breast Cancer- A Systematic Review and Meta-analysis
Ranju Kunwor, Daniel P. Silver, and Maysa Abu-Khalaf

PDF

Infectious complications and preventative strategies following Chimeric Antigen Receptor T-cells (CAR-T cells) therapy for B-cell malignancies
Alfadil Haroon, Ibrahim N. Muhsen, Muhammad Bilal Abid, Abdulwahab Albabtain, Ali Alahmari, Syed Osman Ahmed, Riad El Fakih, and Mahmoud Aljurf

PDF

Adoptive cellular therapy in acute myeloid leukemia: Current scope and challenges
Sankalp Arora, Palash Asawa, Aravind Ramakrishnan, Carlos Bachier, and Navneet S Majhail

PDF

JAK2/STAT5 pathway mutation frequencies in South African BCR/ABL negative MPN patients
Shires K, Rust A, Harryparsad R, Coburn J, and Gopie R

PDF

CAR-T cell Therapies for B-cell Lymphoid Malignancies: Identifying Targets Beyond CD19
Yenny M. Vanegas, Razan Mohty, Martha E. Gadd, Yan Luo, Mahmoud Aljurf, Hong Qin, and Mohamed A. Kharfan-Dabaja

PDF

Understanding the etiology of pancytopenias in the CAR T-cell therapy setting: what we know and what we don’t?
Farah Yassine, Hemant Murthy, Emad Ghabashi, Mohamed A. Kharfan-Dabaja, and Madiha Iqbal

PDF

Next-Generation Chimeric Antigen Receptor T Cells
Dongni Yi, Mia Gergis, Jingmei Hsu, Yang Yang, Xia Bi, Mahmoud Aljurf, and Usama Gergis

PDF

Chimeric Antigen Receptor T-Cell Therapies in Lymphoma Patients with Central Nervous System Involvement
Dongni Yi, Mia Gergis, Ghada Elgohary, Jingmei Hsu, Yang Yang, Xia Bi, and Usama Gergis

PDF

Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies
Yang Yang, Xia Bi, Mia Gergis, Dongni Yi, Jingmei Hsu, and Usama Gergis